Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. [electronic resource]
Producer: 20150608Description: 1257-66 p. digitalISSN:- 1473-4877
- Adolescent
- Adult
- Aged
- Biomarkers -- blood
- Blood Glucose -- metabolism
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Gliclazide -- therapeutic use
- Glycated Hemoglobin -- metabolism
- Humans
- Hydroxychloroquine -- therapeutic use
- Hypoglycemic Agents -- therapeutic use
- Male
- Metformin -- therapeutic use
- Middle Aged
- Pioglitazone
- Sulfonylurea Compounds -- therapeutic use
- Thiazolidinediones -- therapeutic use
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.